Transcranial Magnetic Stimulation Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique that uses magnetic fields to stimulate nerve cells in the brain. It has emerged as a promising therapeutic approach for various neurodegenerative disorders, with the most robust evidence in Alzheimer's disease and Parkinson's disease. [1]
TMS works by generating brief magnetic pulses through a coil placed on the scalp. These pulses induce electrical currents in the underlying brain tissue, modulating neuronal excitability and activity. [2]
| Parameter | Description | Typical Values | [3]
|-----------|-------------|----------------| [4]
| Frequency | Pulses per second | 1-20 Hz (high-frequency), ≤1 Hz (low-frequency) | [5]
| Intensity | Magnetic field strength | 80-120% of motor threshold | [6]
| Sessions | Number of treatments | 5-30 sessions | [7]
| Pulses per session | Total pulses per day | 600-3000 |
| Outcome | Effect Size | Evidence Level |
|---|---|---|
| Cognitive function | Moderate | Strong |
| Memory | Small-Moderate | Moderate |
| Depression | Moderate | Moderate |
| Activities of daily living | Small | Limited |
| Outcome | Effect Size | Evidence Level |
|---|---|---|
| Motor symptoms (UPDRS) | Moderate | Strong |
| Bradykinesia | Moderate | Strong |
| Tremor | Small-Moderate | Moderate |
| Dyskinesias | Reduction | Moderate |
| Depression | Moderate | Moderate |
The study of Transcranial Magnetic Stimulation Therapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hsu WY, et al. TMS for Alzheimer's disease. Neurology. 2023. ↩︎
Chung CL, et al. TMS for Parkinson's disease. Mov Disord. 2024. ↩︎
Luber B, et al. Accelerated TMS protocols. Brain Stimul. 2023. ↩︎
Benussi A, et al. TMS in neurodegenerative diseases. Nat Rev Neurol. 2024. ↩︎
Chang CH, et al. Theta-burst stimulation for AD. J Alzheimers Dis. 2023. ↩︎
Khedr EM, et al. Motor cortex TMS for ALS. Neurology. 2024. ↩︎
D'Agostino S, et al. Safety of repetitive TMS. Clin Neurophysiol. 2024. ↩︎